You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Article metrics

Article menu

Download PDFPDF

XML
Research Article
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019220
Jan 202012120
Feb 202023231
Mar 202026267
Apr 202021218
May 202028284
Jun 202042429
Jul 2020353510
Aug 2020282622
Sep 2020727244
Oct 2020404011
Nov 2020303013
Dec 2020313114
Jan 2021363633
Feb 2021272714
Mar 2021414140
Apr 2021585836
May 2021383833
Jun 2021393950
Jul 2021353541
Aug 2021595943
Sep 2021525238
Oct 2021636362
Nov 2021606049
Dec 2021535343
Jan 2022313221
Feb 2022313322
Mar 2022333323
Apr 2022313318
May 2022272719
Jun 2022798027
Jul 202229299
Aug 2022313410
Sep 2022373833
Oct 2022272724
Nov 2022444412
Dec 2022818115
Jan 2023404224
Feb 2023353514
Mar 2023424214
Apr 2023192010
May 2023303013
Jun 2023161710
Jul 2023272716
Aug 202317177
Sep 2023232314
Oct 202320207
Nov 2023434317
Dec 202330730817
Jan 202421721716
Feb 2024292917
Mar 2024272817
Apr 2024373735
May 2024262620
Jun 2024171814
Jul 2024515119
Aug 2024131416
Total246824841175